Patents
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
07/2004
07/01/2004WO2004014310A3 Novel processes for the preparation of peripheral opioid antagonist compounds and intermediates thereto
07/01/2004WO2003045878A8 2,w-diaminocarboxylic acid compounds
07/01/2004US20040127564 inactivators of antigen-specific T cells; increased half-life
07/01/2004US20040127516 Substituted dimethyl-[1-(1-phenyl-cyclohexyl)-piperidin-3-ylmethyl]-amines and the use of the same as analgesics
07/01/2004US20040127503 17Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
07/01/2004US20040127498 Heterocyclic side chain containing, n-substituted metalloprotease inhibitors
07/01/2004US20040127494 Sulfur compounds such as (2R)-2-[N-(4-Chlorobenzenesulfonyl)-N-(4-methoxybenzyl)amino]-4-methylpentanoic acid amide, used for prophylaxis of neurodegenarative disorders such as Alzheimer's Disease and Down's Syndrome
07/01/2004DE10257785A1 Isophthalsäurederivate Isophthalic acid derivatives
07/01/2004CA2510158A1 Process for the preparation of fexofenadine
06/2004
06/30/2004EP1433783A2 Naphthalenecarboxamides as tachykinin receptor antagonists
06/30/2004EP1433782A1 Process for producing pipecolamide derivative
06/30/2004EP1432687A2 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
06/30/2004EP1432683A1 Novel crystalline polymorphic forms of lercanidipine hydrochloride and processes for their preparation
06/30/2004EP1070049B1 Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors
06/30/2004EP1045693B1 Aminophenoxyacetic acid derivatives as neuroprotectants
06/30/2004CN1509282A 4-(phenyl-piperdin-4-ylidene-methyl)benzamide derivatives and theive use for treating pain, anxiety or gastrointestinal disorders
06/30/2004CN1509271A 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for treatment of pain anxiety or gastrointestinal disorders
06/30/2004CN1508191A Light-resistant clouring agent and composition containing same
06/30/2004CN1155574C Ether muscarinic antagonists
06/29/2004US6756400 Diaromatic compound containing 2-amine groups, useful for treating neuropathic pain
06/29/2004US6756393 Amides and ureas n-substituted with piperidine or nortropane; serotonin inverse agonists or antagonists; antipsychotic
06/29/2004US6756390 Organic acid salt of amlodipine
06/29/2004US6756389 Pharmaceutically active compounds and methods of use
06/29/2004US6756387 Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
06/29/2004US6756378 VLA-4 inhibitor compounds
06/29/2004US6756375 Estrogen receptor modulation; hormone replacement therapy
06/29/2004US6756372 For therapy of autoimmune diseases, alzheimer's disease, atherosclerosis, osteoporosis, rheumatoid arthritis, systemic lupus erythematosus, crohn's disease, ulcerative colitis, multiple sclerosis, guillain-barre syndrome, psoriasis
06/29/2004US6756370 Piperidine alcohols
06/29/2004US6756047 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
06/29/2004US6755875 Piperidine-n-oxy group containing compounds stabilizes white, dyed, dipped, unscented or scented candle wax against discolration and fading
06/29/2004CA2280685C A medicament against infertility and for increasing fertility
06/24/2004WO2004052872A1 Haloalkene compounds, process for their production and pesticides containing them
06/24/2004WO2004052859A1 Erythropoietin production accelerator
06/24/2004WO2004052858A2 Inhibitors of monoamine uptake
06/24/2004WO2004052847A2 Tricyclic steroid hormone nuclear receptor modulators
06/24/2004WO2004052846A1 Tetrahydro-naphthalene derivatives
06/24/2004WO2004052845A1 Tetrahydro-naphthalene derivatives as vanilloid receptor antagonists
06/24/2004WO2004052839A1 Isophtalic acid derivatives
06/24/2004WO2003051841A3 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/24/2004US20040122224 copolycarbons used to form synthetic rubbers having low hysteresis and good compatibility with fillers, such as carbon black and silica; tires, hoses and belts
06/24/2004US20040122194 Functionalized monomers for synthesis of rubbery polymers
06/24/2004US20040122057 Novel mandelic acid derivatives
06/24/2004US20040122051 Methods for treating cognitive impairments or dementia
06/24/2004US20040122050 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors
06/24/2004US20040122049 heterocyclic derivatives containing N-substituted piperidine ring and an amide or urea group; useful for treating rheumatic arthritis
06/24/2004US20040122032 for treating neurodegenerative disorders; mixture with other active ingredients; 1-{2-(3'-chlorobiphenyl-4-yl)-2-oxoethyl}-4-(3-trifluoromethyl-phenyl)-1,2,3,6-tetrahydropyridine for example; Alzheimer's disease, cerebral edema
06/24/2004US20040122017 Melanin concentrating hormone (MCH) modulators; metabolic and eating disorders
06/24/2004US20040122004 such as (1R,2R)-N-[(1S)-2-amino-1-(4-fluorophenyl)-2-oxoethyl]-2-(4-{[{[ethyl(2-hydroxyethyl)amino]carbonyl}(4-fluorophenyl)amino]methyl}phenyl)cyclohexanecarboxamide; for prevention/treatment of cardiovascular disorders
06/24/2004US20040121997 20-hydroxyeicosatetraenoic acid production inhibitors
06/24/2004US20040121994 Novel amides that activate soluble guanylate cyclase
06/23/2004EP1431298A1 Mannitol and glucitol derivatives
06/23/2004EP1431287A1 Optically pure paroxetine precursos
06/23/2004EP1431285A1 Reverse hydroxamic acid derivatives
06/23/2004EP1430032A2 Substituted amides for the treatment of neurological disorders
06/23/2004EP1430027A2 Novel aminoazetidine, -pyrrolidine and -piperidine derivatives
06/23/2004EP1429771A2 Bicyclic compounds as inhibitors of chemokine binding to us28
06/23/2004EP1429767A1 Acylic piperazine and piperidine derivatives which are useful for treating neuronal damage
06/23/2004EP1429765A2 Inhibitors of histone deacetylase
06/23/2004EP1429723A1 Treating effects of excessive reactive oxygen species
06/23/2004EP1353906B1 Process for the preparation of (3-cyano-1h-indol-7-yl)(4-(4-fluorophenethyl)piperazin-1-yl)-methanone and salts thereof
06/23/2004EP1165508B1 Anticancer calcium channel blockers
06/23/2004CN1507435A Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases
06/23/2004CN1154636C Process for preparnig intermediate in preparation of substd. peperidines
06/23/2004CN1154635C Novel compounds with analgesic effect
06/23/2004CN1154483C Use of amines to produce drugs for preventing tumour cell proliferation
06/22/2004US6753447 Functionalized monomers for synthesis of rubbery polymers
06/22/2004US6753429 1,4-disubstituted benzenes as insecticides
06/22/2004US6753409 For treatment of myocardial infarction, stroke, peripheral arterial disease and disseminated intravascular coagulation
06/22/2004US6753346 CETP activity inhibitor
06/22/2004US6753337 Inhibitors of tnf-alpha converting enzyme; treatment of arthritis, inflammation, inflammatory bowel disease etc,
06/22/2004US6753336 Melanin concentrating hormone receptor ligands
06/22/2004US6753335 Delta agonists for nervous system pain
06/22/2004CA2263692C Synthesis of cisapride
06/22/2004CA2135309C Process for preparing n-aliphatic substituted p-phenylenediamines
06/17/2004WO2004050623A1 Methods for preparing phenylalkyne derivatives
06/17/2004WO2004050619A1 Hydroxyethylamine derivatives for the treatment of alzheimer's disease
06/17/2004WO2004050613A2 2-substituted-3-propenamide derivatives and methods of using the same
06/17/2004WO2004050610A2 Modulators of melanocortin receptor
06/17/2004WO2004037796A3 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives
06/17/2004WO2004018414A3 Antibacterial agents
06/17/2004WO2004013282A3 Bis (amino acid) molecular scaffolds
06/17/2004WO2003106421A3 Phenylalkylamines and pyridylalkylamines with serotoninergic receptor affinity
06/17/2004WO2003055879A3 Tropane derivative, chelation product comprising this tropane derivative and a metal or a metal complex, and radiopharmaceutical
06/17/2004US20040116706 Therapeutic ureas
06/17/2004US20040116705 Synthesis method and intermediates of pyridin-2-yl-methylamine
06/17/2004US20040116654 Isolated polypeptides; genetic engineering; quantitative analysis
06/17/2004US20040116518 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
06/17/2004US20040116478 Novel amlodipine camsylate and method for preparing thereof
06/17/2004US20040116457 Agents for improving excretory potency of urinary bladder
06/17/2004US20040116445 Substituted thioacetamides
06/17/2004US20040116439 Serine protease inhibitors
06/17/2004US20040116404 Sulphones which modulate the action of gamma secretase
06/17/2004US20040116353 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
06/17/2004CA2508914A1 Modulators of melanocortin receptor
06/17/2004CA2508325A1 Hydroxyethylamine derivatives for the treatment of alzheimer's disease
06/17/2004CA2507875A1 Methods for preparing phenylalkyne derivatives
06/16/2004EP1428822A2 1-phenylpiperazine derivative as modulators of dopamine neurotransmission
06/16/2004EP1428821A1 Piperidin-4-yl amines with analgesic effect
06/16/2004EP1428820A1 Non-imidazole alkylamines as histamine H-3-receptor ligands and their therapeutic applications
06/16/2004EP1427704A1 Method for producing 4-haloalkylnicotinic acid esters